Management of New Onset Atrial Fibrillation with Rapid Ventricular Response

Initial Assessment and Management

The American College of Cardiology recommends performing immediate synchronized electrical cardioversion if the patient exhibits hemodynamic instability (hypotension, pulmonary edema, ongoing ischemia, or angina) 1, 2, 3
Do not delay anticoagulation in unstable patients 1, 2
Check ECG for pre-excitation (delta waves suggesting WPW syndrome) before administering any AV nodal blocking agents 1, 2, 3

Obtain or review echocardiogram to determine LVEF, as this dictates drug selection, according to the American College of Cardiology 1, 4, 5
For LVEF >40% (Preserved Function), administer IV beta-blockers (metoprolol, esmolol) or non-dihydropyridine calcium channel blockers (diltiazem, verapamil) as first-line agents, as recommended by the American College of Cardiology 1, 2, 5
For LVEF ≤40% (Reduced Function), use IV beta-blockers and/or digoxin; avoid calcium channel blockers entirely as they worsen hemodynamics, according to the American College of Cardiology 1, 4, 6, 3
For COPD or active bronchospasm, use diltiazem or verapamil; avoid beta-blockers, as recommended by the American College of Cardiology 1, 2, 5, 3
For WPW syndrome with pre-excitation, never use AV nodal blockers (beta-blockers, calcium channel blockers, digoxin, adenosine, or amiodarone); use IV procainamide or perform immediate cardioversion, according to the American College of Cardiology 1, 2, 7, 5

Assess stroke risk using CHA₂DS₂-VASc score, as recommended by the American College of Cardiology 5, 7
For CHA₂DS₂-VASc score ≥2, initiate oral anticoagulation immediately, according to the American College of Cardiology 1, 2, 5
Direct oral anticoagulants (DOACs) are preferred over warfarin due to lower intracranial hemorrhage risk, as recommended by the American College of Cardiology 5
Apixaban 5 mg twice daily (or 2.5 mg twice daily if ≥2 of: age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL) 5
If warfarin used, target INR 2.0-3.0 with weekly monitoring during initiation, then monthly when stable, according to the American College of Cardiology 1, 7, 5

If AF duration >48 hours or unknown, require 3 weeks therapeutic anticoagulation before elective cardioversion, as recommended by the American College of Cardiology 1, 2, 7, 3
Alternative: Perform transesophageal echocardiography (TEE) to exclude left atrial thrombus, allowing earlier cardioversion if negative, according to the American College of Cardiology 7, 3
If AF duration <48 hours, may proceed with cardioversion after initiating anticoagulation, as recommended by the American College of Cardiology 7

Continue anticoagulation for minimum 4 weeks after cardioversion in all patients, according to the American College of Cardiology 1, 2, 7, 3
Continue long-term anticoagulation based on CHA₂DS₂-VASc score regardless of rhythm status, as recommended by the American College of Cardiology 5, 3

Hospitalization required for initial rate control achievement requiring IV medications, cardioversion performed, suspected tachycardia-induced cardiomyopathy, or initiation of antiarrhythmic drugs requiring monitoring, according to the American College of Cardiology 3, 1, 6
Discharge criteria: Adequate rate control achieved (<110 bpm at rest), hemodynamically stable, anticoagulation initiated, and adequate medication supply provided, as recommended by the American College of Cardiology 5, 3
Ensure follow-up arranged for INR monitoring if on warfarin, according to the American College of Cardiology 1, 7
Renal function monitoring at least annually for DOAC patients, as recommended by the American College of Cardiology 5

Never use calcium channel blockers in decompensated heart failure or LVEF ≤40%, according to the American College of Cardiology 4, 6, 3
Never use AV nodal blockers (diltiazem, verapamil, beta-blockers, digoxin, adenosine, amiodarone) in WPW with pre-excitation, as they accelerate ventricular rate and can precipitate ventricular fibrillation, as recommended by the American College of Cardiology 1, 2, 7, 5, 3
Never cardiovert without 3 weeks anticoagulation or TEE when AF duration >48 hours or unknown, according to the American College of Cardiology 1, 2, 7, 3
Never discontinue anticoagulation after successful cardioversion if stroke risk factors persist, as recommended by the American College of Cardiology 5, 3